PTC THERAPEUTICS, INC. AND U.S. BANK NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of September 20, 2019Indenture • September 20th, 2019 • PTC Therapeutics, Inc. • Pharmaceutical preparations • New York
INDENTURE dated as of September 20, 2019 between PTC THERAPEUTICS, INC., a Delaware corporation, as issuer (the “Company”, as more fully set forth in Section 1.01) and U.S. BANK NATIONAL ASSOCIATION, a national banking association, as trustee (the “Trustee”, as more fully set forth in Section 1.01).
PTC THERAPEUTICS, INC. 2,475,248 Shares of Common Stock Underwriting AgreementUnderwriting Agreement • September 20th, 2019 • PTC Therapeutics, Inc. • Pharmaceutical preparations • New York
PTC Therapeutics, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule I hereto (the “Underwriters”), for whom you are acting as representative (the “Representative”), an aggregate of 2,475,248 shares of common stock, par value $0.001 per share, of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 371,287 shares of common stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of common stock of the Company to be outstanding after giving effect to the sale of the Underwritten Shares and the Option Shares, to the extent issued, are referred to herein as the “Stock”. To the extent that you are the only Underwriter, all references to “each Underwriter,” “the Underwriters” or “Representative” shall refer to just you.
